Jubilant snags $146.6M US contract to double injectables production
Jubilant HollisterStier, a Spokane-based contract development and manufacturing company (CDMO), received a $146.6 million contract from the U.S. government to double its injectables filling capacity for current and future demand.
Through a total $193 million in funding from the American Rescue Plan, Jubilant HollisterStier will complete the expansion of its manufacturing facility by 2025.
“Jubilant’s expansion will target large pharmaceuticals and biotech companies for parenteral products as well as feature a flexible manufacturing platform able to produce several types of vaccines,” said Amit Arora, President of Jubilant HollisterStier. “This investment will ensure our ability and flexibility to speedily produce quality vaccines and treatments for our customers and be better prepared for any future threats to the country.”